Home/Filings/4/0001415889-25-023897
4//SEC Filing

Raykov Rosty 4

Accession 0001415889-25-023897

CIK 0001211583other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 6:05 PM ET

Size

7.2 KB

Accession

0001415889-25-023897

Insider Transaction Report

Form 4
Period: 2025-09-05
Raykov Rosty
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Stock Options

    2025-09-05$2.45/sh36,207$88,7071,638,793 total
    Exercise: $2.45From: 2016-07-05Exp: 2026-07-05options (36,207 underlying)
  • Exercise/Conversion

    Common shares

    2025-09-05$2.45/sh+36,207$88,70787,293 total
Footnotes (1)
  • [F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1
  • filerCIK 0001468316

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 6:05 PM ET
Size
7.2 KB